0001104659-20-101464.txt : 20200901 0001104659-20-101464.hdr.sgml : 20200901 20200901171332 ACCESSION NUMBER: 0001104659-20-101464 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200831 FILED AS OF DATE: 20200901 DATE AS OF CHANGE: 20200901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Esposito Pamela CENTRAL INDEX KEY: 0001744425 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 201155068 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 a4.xml 4 X0306 4 2020-08-31 0 0001737953 Replimune Group, Inc. REPL 0001744425 Esposito Pamela C/O REPLIMUNE GROUP, INC., 500 UNICORN PARK WOBURN MA 01801 0 1 0 0 Chief Business Officer Common Stock 2020-08-31 4 M 0 5000 1.01 A 117700 D Common Stock 2020-08-31 4 S 0 5000 27.05 D 112700 D Employee Stock Option (right to buy) 1.01 2020-08-31 4 M 0 5000 0 D 2025-11-01 Common Stock 5000 144203 D The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on June 15, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.18. Following the sales reported on this Form 4, the reporting person continues to beneficially own 112,700 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 593,146 shares of the Issuer's common stock, 394,440 of which are exercisable as of the date hereof. The reporting person was granted an option to purchase 149,203 shares of the Issuer's common stock on November 1, 2015. All of the shares underlying the stock option have vested and are exercisable as of the date hereof. /s/ Jean Franchi, attorney-in-fact 2020-09-01